Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 15,152 | 15,843 | 14,704 | 13,428 | 14,677 |
| Cost of Goods | 9,844 | 10,109 | 9,182 | 8,861 | 10,397 |
| Gross Profit | 5,308 | 5,734 | 5,522 | 4,567 | 4,280 |
| Operating Expenses | 8,710 | 9,895 | 8,745 | 9,202 | 9,177 |
| Operating Income | -2,558 | -4,052 | -3,041 | -3,774 | -4,500 |
| Interest Expense | 3,084 | 2,836 | 264 | 2,292 | 2,387 |
| Other Income | 848 | 0 | 55 | 566 | 389 |
| Pre-tax Income | -4,794 | -6,888 | -3,250 | -5,500 | -6,498 |
| Income Tax | -35 | -131 | 67 | -3 | 222 |
| Net Income Continuous | -4,759 | -6,757 | -3,317 | -5,497 | -6,720 |
| Net Income Discontinuous | N/A | N/A | N/A | -3 | -1 |
| Net Income | $-4,759 | $-6,757 | $-3,317 | $-5,500 | $-6,721 |
| EPS Basic Total Ops | -0.46 | -0.71 | -1.85 | -3.59 | -4.40 |
| EPS Basic Continuous Ops | -0.46 | -0.71 | -1.87 | -3.59 | -4.38 |
| EPS Diluted Total Ops | -0.46 | -0.71 | -1.85 | -3.59 | -4.40 |
| EPS Diluted Continuous Ops | -0.46 | -0.71 | -1.87 | -3.59 | -4.38 |
| EPS Diluted Before Non-Recurring Items | -2.15 | -2.75 | -1.85 | N/A | N/A |
| EBITDA(a) | $-1,961 | $-3,899 | $-2,350 | $-3,312 | $-4,271 |